Clinical trial

Dried Blood SPOT Analysis of Everolimus in Cancer Patients (SPOT-study)

NCT02809404

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Everolimus Normalized identity: everolimusView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Dried Blood SPOT Analysis of Everolimus in Cancer Patients (SPOT-study)

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2015-06-01

PhaseN/A

Conditions

Breast Cancerverified · MONDO: breast cancer

Renal Cell Carcinomaverified · MONDO: renal cell carcinoma

Interventions

EverolimusDRUG · verified · RxNorm: everolimus

Sponsors & collaborators

Radboud University Medical Centerlead sponsor

Mapped research locations

NijmegenNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02809404 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.